Allschwil, France

Olivier Valdenaire


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Spotlight: Olivier Valdenaire

Introduction

Olivier Valdenaire is a notable inventor based in Allschwil, France. With a focus on the field of pharmaceuticals, he has made significant strides in innovations that address various medical challenges. His work largely revolves around unique chemical derivatives with applications in treating complex health issues.

Latest Patents

Valdenaire holds one patent for his invention of guanidine derivatives. This patent, which includes the general formula (I), outlines the use of these compounds as neuropeptide FF receptor antagonists. The applications of his invention span across the treatment of pains and hyperalgesia, managing withdrawal symptoms related to addictions such as alcohol, psychotropic drugs, and nicotine. Additionally, his patent addresses the regulation of insulin release, food intake, memory functions, blood pressure, electrolyte and energy metabolism, and the management of urinary incontinence.

Career Highlights

Currently, Olivier Valdenaire is an integral part of Actelion Pharmaceuticals Ltd., a company renowned for its dedication to developing innovative therapies in the pharmaceutical sector. His contributions have positioned him as a key player in advancing therapeutic options that improve patient care and quality of life.

Collaborations

Throughout his career, Valdenaire has collaborated with esteemed colleagues, including Volker Breu and Anja Fecher. These partnerships highlight the collaborative spirit in research and innovation, which is essential for tackling multifaceted health issues and bringing new solutions to the market.

Conclusion

Olivier Valdenaire exemplifies the spirit of innovation in pharmaceuticals with his important patent on guanidine derivatives. His work not only showcases his commitment to addressing significant health challenges but also underscores the vital role of inventors in scientific progress. As he continues his journey at Actelion Pharmaceuticals Ltd., it is anticipated that his innovative contributions will pave the way for new advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…